Cached SEC EDGAR filing history for PLUS THERAPEUTICS, INC. (PSTV), most recently a 10-Q dated 2026-05-15. 10 recent filings across 3 form types are indexed, each linked to the structured per-filing render and the EDGAR source. Every figure on this tab is extracted verbatim from the underlying SEC filing — no AI synthesis, no estimation.
PSTV — 10-Q Filing
Track for AlertsFinancial Highlights
Structured-data extract from the filer's SEC-tagged XBRL. Every value below is sourced from a labeled XBRL concept; hover any cell to see the exact source. No AI summarization, no paraphrasing.
Income Statement
| Item | Mar 31, 2026 | Mar 31, 2025 | YoY |
|---|---|---|---|
| Revenue | — | $1.06M | |
| Cost of Revenue | — | — | |
| Operating Income (Loss) | — | −$3.54M | |
| Net Loss from Continuing Operations(derived) | — | −$17.40M | |
| Net Income (Loss) — Total | — | −$17.40M |
Balance Sheet
| Item | Mar 31, 2026 | Mar 31, 2025 | YoY |
|---|---|---|---|
| Total Assets | — | $12.06M | |
| Total Liabilities | — | $35.70M | |
| Stockholders' Equity | — | −$23.64M | |
| Accumulated Deficit | — | −$510.88M | |
| Cash and Cash Equivalents | — | $9.87M | |
| Shares Outstanding | — | 17.00M |
Cash Flow
| Item | Mar 31, 2026 | Mar 31, 2025 | YoY |
|---|---|---|---|
| Operating Cash Flow | — | −$6.17M |
- 10-Q filed 2025-10-30 · view on EDGAR
- 10-Q filed 2025-05-30 · view on EDGAR
What is a 10-Q?
A quarterly report covering the three months just ended. Includes unaudited condensed financial statements (balance sheet, income statement, cash flow), Management Discussion and Analysis (MD&A), and disclosure of material changes since the last annual report. Required for the first three fiscal quarters; the fourth quarter is rolled into the 10-K.